Published in J Biol Chem on May 03, 2011
Human VRK2 modulates apoptosis by interaction with Bcl-xL and regulation of BAX gene expression. Cell Death Dis (2013) 0.92
Macro histone H2A1.2 (macroH2A1) protein suppresses mitotic kinase VRK1 during interphase. J Biol Chem (2011) 0.91
Vaccinia-related kinase 1 (VRK1) is an upstream nucleosomal kinase required for the assembly of 53BP1 foci in response to ionizing radiation-induced DNA damage. J Biol Chem (2012) 0.88
VRK1 chromatin kinase phosphorylates H2AX and is required for foci formation induced by DNA damage. Epigenetics (2015) 0.84
Luteolin suppresses cancer cell proliferation by targeting vaccinia-related kinase 1. PLoS One (2014) 0.83
Identification of an N-terminal inhibitory extension as the primary mechanosensory regulator of twitchin kinase. Proc Natl Acad Sci U S A (2012) 0.82
Vaccinia-related kinase 1 (VRK1) confers resistance to DNA-damaging agents in human breast cancer by affecting DNA damage response. Oncotarget (2014) 0.79
Sensitivity of the kinase activity of human vaccinia-related kinase proteins to toxic metals. J Biol Inorg Chem (2013) 0.77
Ursolic acid exerts anti-cancer activity by suppressing vaccinia-related kinase 1-mediated damage repair in lung cancer cells. Sci Rep (2015) 0.76
Mutations in CG8878, a novel putative protein kinase, enhance P element dependent silencing (PDS) and position effect variegation (PEV) in Drosophila melanogaster. PLoS One (2014) 0.75
Exploiting image registration for automated resonance assignment in NMR. J Biomol NMR (2015) 0.75
Structural characterization of human Vaccinia-Related Kinases (VRK) bound to small-molecule inhibitors identifies different P-loop conformations. Sci Rep (2017) 0.75
Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28
NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR (1995) 93.94
MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph (1996) 39.73
AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR (1996) 29.55
TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts. J Biomol NMR (2009) 16.09
Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J (1995) 14.45
Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. Proc Natl Acad Sci U S A (1997) 13.28
Version 1.2 of the Crystallography and NMR system. Nat Protoc (2007) 13.01
Automated NMR structure calculation with CYANA. Methods Mol Biol (2004) 9.31
Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell (1995) 9.27
Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. Trends Genet (2004) 3.69
Mechanism of Aurora B activation by INCENP and inhibition by hesperadin. Mol Cell (2005) 3.14
Structure of the pseudokinase VRK3 reveals a degraded catalytic site, a highly conserved kinase fold, and a putative regulatory binding site. Structure (2009) 2.33
Structural insight into the autoinhibition mechanism of AMP-activated protein kinase. Nature (2009) 2.25
REDCAT: a residual dipolar coupling analysis tool. J Magn Reson (2004) 2.03
The vaccinia-related kinases phosphorylate the N' terminus of BAF, regulating its interaction with DNA and its retention in the nucleus. Mol Biol Cell (2006) 2.01
Barrier-to-autointegration factor: major roles in chromatin decondensation and nuclear assembly. J Cell Biol (2002) 1.88
Caenorhabditis elegans BAF-1 and its kinase VRK-1 participate directly in post-mitotic nuclear envelope assembly. EMBO J (2006) 1.81
Quaternary structure of hemoglobin in solution. Proc Natl Acad Sci U S A (2003) 1.77
Defining the conserved internal architecture of a protein kinase. Biochim Biophys Acta (2009) 1.76
The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein. Oncogene (2000) 1.62
Identification of two novel human putative serine/threonine kinases, VRK1 and VRK2, with structural similarity to vaccinia virus B1R kinase. Genomics (1997) 1.55
BAF: roles in chromatin, nuclear structure and retrovirus integration. Trends Cell Biol (2004) 1.49
Global folds of proteins with low densities of NOEs using residual dipolar couplings: application to the 370-residue maltodextrin-binding protein. J Mol Biol (2000) 1.48
Human vaccinia-related kinase 1 (VRK1) activates the ATF2 transcriptional activity by novel phosphorylation on Thr-73 and Ser-62 and cooperates with JNK. J Biol Chem (2004) 1.46
Characterization of three paralogous members of the Mammalian vaccinia related kinase family. J Biol Chem (2003) 1.45
Amino acid contribution to protein solubility: Asp, Glu, and Ser contribute more favorably than the other hydrophilic amino acids in RNase Sa. J Mol Biol (2006) 1.40
Vaccinia virus encodes an essential gene with strong homology to protein kinases. J Biol Chem (1989) 1.37
Mitotic histone H3 phosphorylation by vaccinia-related kinase 1 in mammalian cells. Mol Cell Biol (2007) 1.31
Protein kinases--structure and function. FEBS Lett (1995) 1.29
VRK1 phosphorylates CREB and mediates CCND1 expression. J Cell Sci (2008) 1.27
NHK-1 phosphorylates BAF to allow karyosome formation in the Drosophila oocyte nucleus. J Cell Biol (2007) 1.27
The structure of the C-terminal domain of the protein kinase AtSOS2 bound to the calcium sensor AtSOS3. Mol Cell (2007) 1.23
Structural basis of human p70 ribosomal S6 kinase-1 regulation by activation loop phosphorylation. J Biol Chem (2009) 1.17
Emerging biological functions of the vaccinia-related kinase (VRK) family. Histol Histopathol (2009) 1.09
Kinetic properties of p53 phosphorylation by the human vaccinia-related kinase 1. Arch Biochem Biophys (2002) 1.05
Protein kinases, their function and implication in cancer and other diseases. Folia Biol (Praha) (2006) 0.84
The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites. Cell (2012) 2.84
A B-box 2 surface patch important for TRIM5alpha self-association, capsid binding avidity, and retrovirus restriction. J Virol (2009) 2.03
FKBP family proteins: immunophilins with versatile biological functions. Neurosignals (2008) 1.94
Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer. Nat Mater (2006) 1.84
Heterogeneous nuclear ribonucleoprotein C modulates translation of c-myc mRNA in a cell cycle phase-dependent manner. Mol Cell Biol (2003) 1.82
Phosphatidylinositol monophosphate-binding interface in the oomycete RXLR effector AVR3a is required for its stability in host cells to modulate plant immunity. Proc Natl Acad Sci U S A (2011) 1.59
Domain 2 of nonstructural protein 5A (NS5A) of hepatitis C virus is natively unfolded. Biochemistry (2007) 1.53
Solution structure of an Arabidopsis WRKY DNA binding domain. Plant Cell (2005) 1.45
KUJIRA, a package of integrated modules for systematic and interactive analysis of NMR data directed to high-throughput NMR structure studies. J Biomol NMR (2007) 1.44
Solution structure of the B3 DNA binding domain of the Arabidopsis cold-responsive transcription factor RAV1. Plant Cell (2004) 1.40
Preparation, functional characterization, and NMR studies of human KCNE1, a voltage-gated potassium channel accessory subunit associated with deafness and long QT syndrome. Biochemistry (2007) 1.35
An engineered Escherichia coli tyrosyl-tRNA synthetase for site-specific incorporation of an unnatural amino acid into proteins in eukaryotic translation and its application in a wheat germ cell-free system. Proc Natl Acad Sci U S A (2002) 1.35
An unnatural base pair for incorporating amino acid analogs into proteins. Nat Biotechnol (2002) 1.35
Contribution of E3-ubiquitin ligase activity to HIV-1 restriction by TRIM5alpha(rh): structure of the RING domain of TRIM5alpha. J Virol (2011) 1.34
NMR solution structure of the N-terminal domain of hERG and its interaction with the S4-S5 linker. Biochem Biophys Res Commun (2010) 1.34
A novel zinc-binding motif revealed by solution structures of DNA-binding domains of Arabidopsis SBP-family transcription factors. J Mol Biol (2004) 1.31
Prostaglandin E2 regulates tumor angiogenesis in prostate cancer. Cancer Res (2008) 1.31
Mitotic histone H3 phosphorylation by vaccinia-related kinase 1 in mammalian cells. Mol Cell Biol (2007) 1.31
Structural insight into the zinc finger CW domain as a histone modification reader. Structure (2010) 1.30
VRK1 phosphorylates CREB and mediates CCND1 expression. J Cell Sci (2008) 1.27
Mouse period 2 mRNA circadian oscillation is modulated by PTB-mediated rhythmic mRNA degradation. Nucleic Acids Res (2008) 1.27
BiP internal ribosomal entry site activity is controlled by heat-induced interaction of NSAP1. Mol Cell Biol (2006) 1.25
Expression of G protein coupled receptors in a cell-free translational system using detergents and thioredoxin-fusion vectors. Protein Expr Purif (2005) 1.24
Structural basis for the sequence-specific RNA-recognition mechanism of human CUG-BP1 RRM3. Nucleic Acids Res (2009) 1.23
RING domain mutations uncouple TRIM5α restriction of HIV-1 from inhibition of reverse transcription and acceleration of uncoating. J Virol (2011) 1.23
Oleic acid and peanut oil high in oleic acid reverse the inhibitory effect of insulin production of the inflammatory cytokine TNF-alpha both in vitro and in vivo systems. Lipids Health Dis (2009) 1.21
The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgamma. Structure (2004) 1.19
Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death. J Cell Sci (2007) 1.17
Protein kinase Cdelta-mediated proteasomal degradation of MAP kinase phosphatase-1 contributes to glutamate-induced neuronal cell death. J Cell Sci (2006) 1.16
Rhythmic serotonin N-acetyltransferase mRNA degradation is essential for the maintenance of its circadian oscillation. Mol Cell Biol (2005) 1.15
Solution structure of the RWD domain of the mouse GCN2 protein. Protein Sci (2004) 1.13
Rhythmic control of AANAT translation by hnRNP Q in circadian melatonin production. Genes Dev (2007) 1.13
Reduced native state stability in crowded cellular environment due to protein-protein interactions. J Am Chem Soc (2013) 1.13
Solution structure of the SWIRM domain of human histone demethylase LSD1. Structure (2006) 1.12
Highly efficient protein expression and purification using bacterial hemoglobin fusion vector. Plasmid (2005) 1.12
DNA-binding domains of plant-specific transcription factors: structure, function, and evolution. Trends Plant Sci (2012) 1.12
Osteopontin: a potentially important therapeutic target in cancer. Expert Opin Ther Targets (2011) 1.11
Phosphorylation of a novel zinc-finger-like protein, ZPR9, by murine protein serine/threonine kinase 38 (MPK38). Biochem J (2002) 1.11
Sensitization of epidermal growth factor-induced signaling by bradykinin is mediated by c-Src. Implications for a role of lipid microdomains. J Biol Chem (2003) 1.11
Solution structure of the extraterminal domain of the bromodomain-containing protein BRD4. Protein Sci (2008) 1.11
Negative regulation of ERK activity by VRK3-mediated activation of VHR phosphatase. Nat Cell Biol (2006) 1.10
Solution structure and siRNA-mediated knockdown analysis of the mitochondrial disease-related protein C12orf65. Proteins (2012) 1.10
Structures of the first and second double-stranded RNA-binding domains of human TAR RNA-binding protein. Protein Sci (2011) 1.10
Improving cell-free protein synthesis for stable-isotope labeling. J Biomol NMR (2007) 1.09
Regulation of transforming growth factor-beta signaling and PDK1 kinase activity by physical interaction between PDK1 and serine-threonine kinase receptor-associated protein. J Biol Chem (2005) 1.08
The flexible loop of Bcl-2 is required for molecular interaction with immunosuppressant FK-506 binding protein 38 (FKBP38). FEBS Lett (2005) 1.08
The Tohoku Medical Megabank Project: Design and Mission. J Epidemiol (2016) 1.08
Solution structure of a BolA-like protein from Mus musculus. Protein Sci (2004) 1.07
3-Phosphoinositide-dependent PDK1 negatively regulates transforming growth factor-beta-induced signaling in a kinase-dependent manner through physical interaction with Smad proteins. J Biol Chem (2007) 1.07
Solution structure of the SEA domain from the murine homologue of ovarian cancer antigen CA125 (MUC16). J Biol Chem (2004) 1.06
Periostin-binding DNA aptamer inhibits breast cancer growth and metastasis. Mol Ther (2013) 1.06
Extracellular ATP mediates necrotic cell swelling in SN4741 dopaminergic neurons through P2X7 receptors. J Biol Chem (2007) 1.05
Solution structure of the PWWP domain of the hepatoma-derived growth factor family. Protein Sci (2005) 1.04
Solution structure of the major DNA-binding domain of Arabidopsis thaliana ethylene-insensitive3-like3. J Mol Biol (2005) 1.04
Solution structure of the catalytic domain of the mitochondrial protein ICT1 that is essential for cell vitality. J Mol Biol (2010) 1.04
Structural basis for the dual RNA-recognition modes of human Tra2-β RRM. Nucleic Acids Res (2010) 1.04
Functional and structural basis of the nuclear localization signal in the ZIC3 zinc finger domain. Hum Mol Genet (2008) 1.03
Crystal structure of the RUN domain of the RAP2-interacting protein x. J Biol Chem (2006) 1.03
Structural basis for mutual relief of the Rac guanine nucleotide exchange factor DOCK2 and its partner ELMO1 from their autoinhibited forms. Proc Natl Acad Sci U S A (2012) 1.02
A robust two-step PCR method of template DNA production for high-throughput cell-free protein synthesis. J Struct Funct Genomics (2008) 1.01
Solution structure of the RNA binding domain in the human muscleblind-like protein 2. Protein Sci (2009) 1.01
Structures and evolutionary origins of plant-specific transcription factor DNA-binding domains. Plant Physiol Biochem (2008) 1.01
Molecular characterization of FK-506 binding protein 38 and its potential regulatory role on the anti-apoptotic protein Bcl-2. Biochem Biophys Res Commun (2005) 1.00
Site-specific functionalization of proteins by organopalladium reactions. Chembiochem (2007) 1.00
Structural and functional differences of SWIRM domain subtypes. J Mol Biol (2007) 1.00
The C-terminal BAG domain of BAG5 induces conformational changes of the Hsp70 nucleotide-binding domain for ADP-ATP exchange. Structure (2010) 1.00
Osteopontin: an emerging therapeutic target for anticancer therapy. Expert Opin Ther Targets (2007) 0.99
Combinatorial mutagenesis to restrict amino acid usage in an enzyme to a reduced set. Proc Natl Acad Sci U S A (2002) 0.99
Osteopontin as a therapeutic target for cancer. Expert Opin Ther Targets (2014) 0.99
Solution structure of an atypical WW domain in a novel beta-clam-like dimeric form. FEBS Lett (2007) 0.99
Tau phosphorylation and cleavage in ethanol-induced neurodegeneration in the developing mouse brain. Neurochem Res (2010) 0.99
Essential role of 3'-untranslated region-mediated mRNA decay in circadian oscillations of mouse Period3 mRNA. J Biol Chem (2006) 0.99